Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Connect Biopharma Holdings (CNTB) Assets Average (2025)

Connect Biopharma Holdings (CNTB) has disclosed Assets Average for 1 consecutive years, with $61.7 million as the latest value for Q4 2025.

  • Quarterly Assets Average changed N/A to $61.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $61.7 million through Dec 2025, changed N/A year-over-year, with the annual reading at $78.7 million for FY2025, 31.18% down from the prior year.
  • Assets Average hit $61.7 million in Q4 2025 for Connect Biopharma Holdings, down from $75.0 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $97.0 million in Q1 2025 to a low of $61.7 million in Q4 2025.